Hyaluronate lyase

BE0001361ProteinStreptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4)

Hyaluronate lyase (Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4)) is a protein target in DrugBank. It is acted on by 9 drugs in DrugBank.

UniProtKB entry
Q54873Swiss-Prot
Cellular location
Secreted
Residues / weight
1,066 residues · 120,771 Da
Also known as
4.2.2.1 · Hyaluronidase · HYase

Resolves to

Protein
UniProtQ54873UniProt nameHYSA_STRPN
Gene
GenBank14971788
Pharmacology
KEGGspn:SP_0314
Structure
PDB1C82PDB1EGUPDB1F9G
Drugs

What you can answer from here — as of September 07, 2019

9DrugsApproved to experimental, with action, bond type and pharmacological action
Sign in
5GO termsFunction, process and component, as structured annotations
Sign in
4Pfam domainsDomain architecture mapped to Pfam families and clans
Sign in
20+ReferencesStructured and connected to the statements they support
Sign in

Which approved drugs act on Hyaluronate lyase, how selective are they, and which programs against it are still in active trials?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In